Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qizhi Capsule plus abiraterone/prednisone in metastatic castration-resistant prostate cancer
CTR20201222Phase 2Active
- Sponsor
- Zhongyao Biotech
- Start
- Jun 2020
- Countries
- 1
01
Overview
A Phase 2 trial of Qizhi capsule in metastatic castration-resistant prostate cancer (mCRPC), sponsored by Zhongyao Biotech. Started Jun 2020; status: active.
02
Drugs
Qizhi capsule
03
Conditions
metastatic castration-resistant prostate cancer (mCRPC)
Beyond the preview
Go deeper on CTR20201222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20201222.